Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

  • [1]Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95(4), 343-53 (2004)

  • [2]Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation 107(24), 3093-100 (2003)

  • [3]Shantsila E, Watson T, Lip GY. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 49(7), 741-52 (2007)

  • [4]Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res 78(3), 413-21 (2008)

  • [5]Jujo K, Ii M, Losordo DW. Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 45(4): 530-44 (2008)

  • [6]Hung HS, Shyu WC, Tsai CH, Hsu SH, Lin SZ. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases. Cell Transplant 18(9), 1003-12 (2009)

  • [7]Frederick JR, 3rd FJR, McCormick RC. Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis. Circulation 122(11 Suppl), S107-17 (2010)

  • [8]Huang PH, Chen YH, Wang CH. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 29(8), 1179-84 (2009)

  • [9]Ceradini DJ, Kulkarni AR, Callaghan MJ. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10(8), 858-64 (2004)

  • [10]Rosova I, Dao M, Capoccia B, Link D, Nolta JA. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26(8), 2173-82 (2008)

  • [11]Mittal M, Gu XQ, Pak O. Hypoxia induces K(v) channel current inhibition by increased NADPH oxidase-derived reactive oxygen species. Free Radic Biol Med 52(6):1033-42 (2012)

  • [12]Kim JH, Song SY, Park SK, Song SU, Xia Y, Sung JH. Primary involvement of NADPH oxidase 4 in hypoxia-induced generation of reactive oxygen species in adipose-derived stem cells. Stem Cells Dev 21(12): 2212-21 (2012)

  • [13]Khachi S, Zhu Y, Yang GY. Preparation and analysis of endothelial progenitor cells associated with angiogenesis. Methods Mol Biol 621, 139-48 (2010)

  • [14]Wu BJ, Midwinter RG, Cassano C. Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol 29(10), 1537-42 (2009)

  • [15]Kalka C, Masuda H, Takahashi T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97(7), 3422-7 (2000)

  • [16]Kong D, Melo LG, Mangi AA. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109(14), 1769-75 (2004)

  • [17]Arnaoutova I, Kleinman HK. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 5(4), 628-35 (2010)

  • [18]Lee SD, Kuo WW, Bau DT, Ko FY, Wu FL, Kuo CH, Tsai FJ, Wang PS, Lu MC, Huang CY. The coexistence of nocturnal sustained hypoxia and obesity additively increases cardiac apoptosis. J Appl Physiol 104(4), 1144-53 (2008).

  • [19]Chartoumpekis D, Ziros PG, Psyrogiannis A, Kyriazopoulou V, Papavassiliou AG, Habeos IG. Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway. Biochem Biophys Res Commun 396(2), 463-6 (2010)

  • [20]Dai T, Zheng H, Fu GS. Hypoxia confers protection against apoptosis via the PI3K/Akt pathway in endothelial progenitor cells. Acta Pharmacol Sin 29(12), 1425-31 (2008)

  • [21]Lee DS, Kim KS, Ko W. The cytoprotective effect of sulfuretin against tert-butyl hydroperoxide-induced hepatotoxicity through Nrf2/ARE and JNK/ERK MAPK-mediated heme oxygenase-1 expression. Int J Mol Sci 15(5), 8863-77 (2014)

  • [22]Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103(11): 1204-19 (2008).

  • [23]Jiang BH, Semenza GL, Bauer C, Marti HH. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol 271(4 Pt 1), C1172-80 (1996)

  • [24]Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL. Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem 272(31), 19253-60 (1997)

  • [25]Bosch-Marce M, Okuyama H, Wesley JB. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 101(12), 1310-8 (2007)

  • [26]Simon MP, Tournaire R, Pouyssegur J. The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. J Cell Physiol 217(3), 809-18 (2008)

  • [27]Mittal M, Roth M, Konig P. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res 101(3), 258-67 (2007)

  • [28]Patterson AJ, Xiao D, Xiong F, Dixon B, Zhang L. Hypoxia-derived oxidative stress mediates epigenetic repression of PKC{varepsilon} gene in foetal rat hearts. Cardiovasc Res 93(2), 302-310 (2011)

  • [29]Wu ML, Ho YC, Yet SF. A Central Role of Heme Oxygenase-1 in Cardiovascular Protection. Antioxid Redox Signal 15(7), 1835-1846 (2011)

  • [30]Ke B, Shen XD, Gao F. Small interfering RNA targeting heme oxygenase-1 (HO-1) reinforces liver apoptosis induced by ischemia-reperfusion injury in mice: HO-1 is necessary for cytoprotection. Hum Gene Ther 20(10), 1133-42 (2009)

  • [31]Lin HH, Chen YH, Yet SF, Chau LY. After vascular injury, heme oxygenase-1/carbon monoxide enhances re-endothelialization via promoting mobilization of circulating endothelial progenitor cells. J Thromb Haemost 7(8), 1401-8 (2009)

  • [32]Bussolati B, Ahmed A, Pemberton H. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103(3), 761-6 (2004)

  • [33]Lin HH, Chen YH, Chang PF, Lee YT, Yet SF, Chau LY. Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. J Mol Cell Cardiol 45(1), 44-55 (2008)

  • [34]Suzuki M, Iso-o N, Takeshita S. Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Biochem Biophys Res Commun 302(1), 138-43 (2003)

  • [35]Ichihara S, Yamada Y, Liu F. Ablation of the transcription factor Nrf2 promotes ischemia-induced neovascularization by enhancing the inflammatory response. Arterioscler Thromb Vasc Biol 30(8), 1553-61 (2010)

  • [36]Barajas B, Che N, Yin F. NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection. Arterioscler Thromb Vasc Biol 31(1), 58-66 (2011)

  • [37]Malec V, Gottschald OR, Li S, Rose F, Seeger W, Hanze J. HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radic Biol Med 48(12), 1626-35 (2010)

  • [38]Yun SP, Lee MY, Ryu JM, Song CH, Han HJ. Role of HIF-1alpha and VEGF in human mesenchymal stem cell proliferation by 17beta-estradiol: involvement of PKC, PI3K/Akt, and MAPKs. Am J Physiol Cell Physiol 296(2), C317-26 (2009)

  • [39]Liu H, Xue W, Ge G. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs. Biochem Biophys Res Commun. 401 (4), 509-15 (2010)

  • [40]Soeda A, Park M, Lee D. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28(45), 3949-59 (2009)

  • [41]Weidemann A, Johnson RS. Biology of HIF-1alpha. Cell Death Differ 15(4), 621-7 (2008)

  • [42]Yee KM, Spivak-Kroizman TR, Powis G. HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci 33(11), 526-34 (2008)

  • [43]Kim TH, Hur EG, Kang SJ. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1{alpha}. Cancer Res 71(6), 2260–2275 (2011)

Article Metrics

  • Information

  • Download

  • Contents

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

1 Jan 2016Article

Hypoxia increases Nrf2-induced HO-1 expression via the PI3K/Akt pathway

Ranzun Zhao 1, Jian Feng 1, Guoxiang He 1,*
Affiliation
Article Info

1 Department of Cardiology, Southwest Hospital, The Third Military Medical University, Chongqing City, 400038, P.R. China

Abstract

Accumulating evidence indicates that transient hypoxic preconditioning improves the resistance of endothelial progenitor cells (EPCs) to severe hypoxia and enhances the therapeutic potential of EPC-based therapies used in vascular repair and ischemic disease. However, the mechanisms underlying these processes remain unknown. This study tested the hypothesis that hypoxic preconditioning activates nuclear factor E2-related factor 2 (Nrf2) and the expression of its target genes, which improves biological functioning and resistance to hypoxia. Exposure to hypoxia after small interfering RNA (siRNA)-mediated knockdown of Nrf2 resulted in increased apoptosis, impaired proliferation, and angiogenesis in vitro. These changes were due to the activation of Nrf2 nuclear translocation via the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway and subsequent increase in the expression of the Nrf2 target gene heme oxygenase 1 (HO-1). Moreover, the hypoxia-induced secretion of hypoxia-inducible factor 1-α (HIF-1α) in EPCs was inhibited by Nrf2 siRNA. In conclusion, the increased resistance to hypoxia and improved therapeutic potential of EPCs, as a result of hypoxia preconditioning, are mediated by the PI3K/Akt-Nrf2-HO-1 signaling pathway and the secretion of HIF-1α after Nrf2 activation.

Keywords

  • Hypoxia Preconditioning
  • Endothelial Progenitor Cells
  • Nuclear Factor-E2-related factor 2
  • Heme Oxygenase-1

References